← Back to catalogue
Research draft

nigericin

vr.tr.nigericin · thing-q7033077

Enable an AI agent to recognise nigericin, assess a sample's chemical and functional state, and judge its suitability for a specified research use.

Thing Registry Physical world and living systems PHY.MAT

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

Researched by: Codex

Bundle → Layer → Finding → Questions Filled

7 bundles · 13 layers · 19 findings · 40 questions

Nigericin identity Establish which chemical entity a nigericin-labelled material represents.

Molecular recognition

Anchor recognition to the nigericin molecular structure.

Structure confirmation

Record structural evidence sufficient to distinguish nigericin from related polyether compounds.

  1. Which reference structure and stereochemical specification define nigericin for this entry? definition
  2. Which analytical evidence establishes that the sample matches that structure rather than merely showing similar activity? measurement

Form and identifiers

Resolve the relationship between the parent substance and the supplied material.

Form-qualified identity

Keep free acid, counterion, solvation, and identifier scope explicit within the existing registry boundary.

  1. Is the material the free acid, a specified salt, a solvate, or an unresolved preparation? definition
  2. Which CAS, PubChem, ChEBI, and EC records apply to that exact form, and which records were checked? provenance
  3. Which label names denote nigericin itself and which denote a formulation containing it? boundary
Lot content and integrity Determine how much identified nigericin a sample contains and whether it remains usable.

Assayed composition

Connect declared purity to quantitative material content.

Content basis

Separate nigericin mass content from chromatographic area purity and other constituents.

  1. Does the reported purity measure mass fraction, chromatographic area, or another quantity? measurement
  2. How do water, residual solvent, counterion, and detected impurities affect the amount of nigericin represented by a weighed sample? measurement
  3. Which lot-specific certificate or analysis supports the declared content? provenance

Integrity over time

Assess whether handling history has compromised chemical or functional quality.

Stability and retest

Tie continued suitability to evidence for the relevant solid or solution form.

  1. What storage and opening history is recorded for this nigericin lot or stock? provenance
  2. Which measurements detect loss of nigericin content, impurity growth, or loss of transport activity? measurement
  3. What evidence warrants continued use, retesting, or quarantine? action
Physical state and preparation Represent the material state and concentration available to an experiment.

Form-dependent properties

Record physical properties with their chemical form and measurement conditions.

Solubility and thermal behaviour

Qualify physical constants rather than transferring values between unspecified preparations.

  1. What nigericin solubility is supported in the relevant solvent or medium at the stated temperature and pH? measurement
  2. Do reported thermal values describe melting, decomposition, or boiling, and for which form and measurement conditions? measurement

Available concentration

Translate assayed material into a defensible preparation concentration.

Concentration validity

Track formula-mass basis, dilution, and evidence of incomplete dissolution.

  1. Which chemical form, formula mass, and content correction underlie the reported molar concentration? measurement
  2. Is the working preparation fully dissolved after dilution, and how was this assessed? measurement
  3. What preparation evidence is required before comparing this exposure with another nigericin experiment? action
Potassium-proton transport Describe nigericin activity through measured ion exchange and its environmental dependencies.

Exchange mechanism

Identify the coupled transport process supported in the tested system.

Coupling and selectivity

Distinguish evidence for coupled exchange from ion binding or nonspecific membrane leakage.

  1. What measurements support coupled K+/H+ exchange and its stoichiometry in this system? measurement
  2. Do reported selectivity values describe binding affinity, transport rate, or a downstream biological response? boundary
  3. Which competing ions and membrane conditions were included when selectivity was measured? measurement

Gradient-dependent performance

Connect activity to gradients, membranes, and exposure.

Transport operating context

Make direction and extent of ion redistribution conditional on the actual test environment.

  1. What potassium concentrations and pH values occur on each membrane side before and after exposure? measurement
  2. How do nigericin concentration, exposure time, temperature, and membrane composition affect the observed transport? measurement
  3. What evidence shows that the intended gradient perturbation or pH equilibration was achieved? action
Research response interpretation Connect nigericin exposure to observed responses without assigning unsupported pathway specificity.

Experimental role

Specify the purpose and context of nigericin use.

Context-qualified response

Keep ion-gradient manipulation, pH calibration, antimicrobial testing, and cellular stimulation distinguishable.

  1. What role is nigericin intended to serve in this experiment, and what observable result defines success? definition
  2. Which cell or membrane system, priming state, medium, concentration, and duration qualify the response? measurement

Causal and assay limits

Separate observed effects from conclusions requiring additional controls.

Response attribution

Require controls that distinguish ion redistribution, pathway activation, and general loss of viability.

  1. Which controls distinguish the intended response from vehicle effects, nonspecific toxicity, and assay interference? measurement
  2. What evidence distinguishes NLRP3 involvement from NLRP1 involvement or inflammasome-independent responses in this system? boundary
  3. Which conclusions remain unsupported even if the nigericin positive control produces a signal? boundary
Handling and use constraints Bind handling decisions to the identified nigericin material and applicable documentation.

Hazard evidence

Establish the documented hazards and unresolved safety information.

Form-specific classification

Record applicable classifications without assuming that all nigericin products have identical documentation.

  1. Which current SDS applies to the exact free acid, salt, or solution being handled? provenance
  2. What GHS classifications and exposure routes does that document identify, under which jurisdiction? definition
  3. Are substance-specific exposure limits documented, or is their status unresolved? provenance

Permitted material actions

Translate verified documentation into decisions for the intended research setting.

Handling disposition

Determine applicable storage, exposure-control, spill, and waste requirements.

  1. Which documented controls apply to weighing the solid versus handling a nigericin solution? action
  2. What storage, spill-response, and disposal requirements apply to this material and its solvent? action
  3. What evidence establishes that the proposed use is permitted in the relevant facility and jurisdiction? provenance
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of nigericin this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these kinds and varieties hold for the sense of nigericin this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of nigericin this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of nigericin this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these typical measurements hold for the sense of nigericin this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of nigericin this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of nigericin this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.MAT

What it is Filled

Nigericin is a microbial polyether antibiotic that acts as a mobile ion carrier, exchanging potassium ions for protons across lipid membranes and thereby altering ion and pH gradients.

In scope

  • Molecular identity, stereochemistry, identifiers, and distinction between free acid and supplied salts
  • Lot composition, purity, concentration, and analytical evidence
  • Physical state, solubility, storage history, and stability
  • Potassium-proton exchange under specified membrane and solution conditions
  • Suitability and interpretation limits for ion-gradient and cellular research
  • Form-specific hazard documentation and permitted handling

Out of scope

  • Supplier products, packaging, pricing, and procurement workflows
  • Producing organisms and fermentation or synthesis processes
  • Complete inflammasome, mitochondrial, or cell-death pathway models
  • Experimental protocols and instrument operation
  • Clinical treatment decisions and therapeutic efficacy
  • Other ionophores as independently modelled substances

Why it exists Filled

Enable an AI agent to recognise nigericin, assess a sample's chemical and functional state, and judge its suitability for a specified research use.

Distinguishing features Filled

  • Require a structure and stereochemistry match rather than identification from antibiotic activity alone; nigericin is a polyether antibiotic with free-acid formula C40H68O11. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/Nigericin)
  • Distinguish the free acid, PubChem CID 34230, from sodium nigericin, CID 16760591 and formula C40H67NaO11; a shared parent name does not establish identical weighing or concentration calculations. [PubChem sodium nigericin](https://pubchem.ncbi.nlm.nih.gov/compound/16760591)
  • Test for coupled, electroneutral potassium-proton exchange when distinguishing nigericin's transport mechanism from electrogenic potassium transport; transport behaviour supplements chemical identification. [Primary study](https://pmc.ncbi.nlm.nih.gov/articles/PMC10786283/)
  • Do not identify nigericin by an inflammasome readout or label it exclusively NLRP3-specific: a primary study also reports NLRP1 activation in human epithelial cells. [Primary study](https://pmc.ncbi.nlm.nih.gov/articles/PMC10786283/)

What robots and AI may and may not do Filled

Must not

  • Assist anyone in using it to harm people or animals.
  • Recommend it as a treatment or supplement for a person.
  • Give handling information beyond its safety data sheet that lowers barriers to misuse.
  • Dispose of it in drains or general waste.

Only with a human decision

  • Ordering, transferring or disposing of stock.
  • Using it in any study involving animals.

May

  • Identify nigericin as a potassium-proton ionophore used in research, citing sources.
  • Report the grade, storage and safety data of a held research stock.

Moral aspects Filled

  • It disrupts cellular ion balance and is toxic, so careless handling endangers workers.
  • Research toxins require control to prevent misuse.

Who is affected

  • Laboratory workers
  • Research animals
  • Waste handlers

Owners Filled

Steward

The laboratory that holds the stock; institutional safety officers oversee its use.

Master systems

  • Laboratory chemical inventories

Links to other meta-models Missing, in the backlog

Not described yet. This gap is in the card backlog.

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.nigericin
  • Wikidata: Q7033077 (https://www.wikidata.org/wiki/Q7033077)

Direct properties required Filled

  • Chemical identity: Structure with stereochemistry; molecular formula; form-qualified CAS, PubChem, ChEBI, and EC identifiers
  • Supplied chemical form: Free acid, specified salt, specified solvate, or unresolved
  • Nigericin content and purity: Mass fraction %, chromatographic area %, and water or residual-solvent content, each with method
  • Preparation concentration: mg/mL or mmol/L, with chemical form and assay correction
  • Physical and solution state: Solid or solution; solvent; dissolved, precipitated, or unresolved; temperature in °C
  • Condition-qualified physical constants: Solubility in mg/mL; melting or decomposition temperature in °C; boiling data only if supported, with pressure
  • Ion-transport conditions: K+ and Na+ concentrations in mmol/L on both membrane sides; pH; temperature in °C; membrane composition
  • Functional potency: Transport rate or concentration-response endpoint with assay, exposure duration, and reference lot
  • Biological test context: Cell or membrane system, priming state, medium, controls, and measured endpoint
  • Handling eligibility: Approved for specified use, restricted, quarantined, or unresolved; linked SDS version and jurisdiction

Recognition required Filled

  • Supplied as a small quantity of white solid or solution in a labelled vial.
  • Not identifiable by sight; label and analysis settle identity.

Capabilities and actions required Filled

  • Resolve a labelled material to nigericin and its explicitly stated chemical form.
  • Compare lots using identity, content, impurity, and functional evidence.
  • Calculate form-corrected concentrations from verified material content.
  • Assess whether a preparation is suitable for a specified ion-gradient or cellular assay.
  • Interpret observed responses against transport conditions and pathway-specific controls.
  • Determine whether storage, handling, or disposal actions meet the applicable documented requirements.

Hazards and failure modes required Filled

  • Toxic exposure through skin contact or ingestion.
  • Contaminated experiments from wrong concentration or degraded stock.

Standards and interfaces required Filled

  • Globally Harmonized System of Classification and Labelling of Chemicals (GHS), United Nations.

Context of use required Filled

  • Nigericin is used in laboratory research to study ion transport and pH gradients across biological membranes.
  • It is also used in cell biology research investigating inflammasome activation and associated inflammatory responses.

Sources Filled

  1. Wikidata item Q7033077: nigericin - identity and sense of the item
  2. Wikipedia: Nigericin - general description of the item

Open questions

  • Which CAS and EC identifiers unambiguously map to the free acid and each supplied salt, and which historical synonyms denote exactly the same stereochemical entity?
  • Which measured solubility, thermal, and storage-stability values are reliable for each material form, and are any reported boiling values experimentally supported?
  • What minimum analytical and functional evidence is sufficient to accept a lot, particularly when its certificate reports only chromatographic area purity?
  • Under which membrane and ionic conditions does nigericin transport competing ions, and how do those conditions limit potassium-selective or pH-clamping interpretations?
  • Which current hazard classifications, exposure limits, and use restrictions apply to the exact preparation in the intended jurisdiction?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q7033077/spec.json